BELGRADE, Serbia, Sept. 10 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com The company is pleased to announce that its operating subsidiary Slavica Bio Chem www.slavicabiochem.com has acquired new equipment for its research work.
The equipment is accessory mini Protean Tetra System from BioRad. http://www.expressionproteomics.com/LifeScience/pdf/Bulletin_3095.pdf
Dr.Ivana Gadjanski HTDS Medical Liaison Correspondent said: "To our followers who are interested in what this apparatus does in summary, Mini Protean Tetra System is a system for 2D electrophoresis which can be used for Western blotting. The new system runs both hand cast gels and Ready Gel Precast Gels interchangeably. The new apparatus will significantly enhance the sample processing procedure. The cell can run one or four gels, and the mini tank is compatible with other Bio-Rad electrode modules for tank blotting, 2D electrophoresis and electroelution".
In other company news, the company has received several unsolicited proposals from other medical companies for its rights in the cancer research and anti aging projects. The company is also considering a merger proposal of its cancer research and anti aging project only, and the positive impact and values this exercise may bring upon the whole organization.
Originally the details were very sketchy and not worth mentioning in a news release or a filing. Over time this began to crystallize and now the company is of the opinion that this is a becoming a significant event, which its shareholders and followers should be made aware of.
The company has scheduled October 7 to October 11 as a date to review, and discuss the split off, sale or merger of its cancer research and anti aging projects and expects to make an announcement on this topic shortly thereafter.
The company will provide further updates on the aforementioned merger / sale of its cancer research and anti aging projects via Pink Sheets filing service with any operational updates in order to keep its followers informed.
More updates on other business activities of Slavica Bio Chem and Mellow Hope the company's China based operations will follow shortly and on a timely basis.
Safe Harbor Statement
Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
|SOURCE Hard to Treat Diseases|
Copyright©2009 PR Newswire.
All rights reserved